The document summarizes the experience of two clinicians in treating traumatic wounds with a TLC-NOSF dressing. It describes two case studies where the dressing helped heal wounds that had previously failed to respond to conventional treatments. In the first case, a 76-year-old woman's leg wound healed completely within 9 weeks with the dressing. In the second case, a 23-year-old woman's wound under a skin graft epithelialized fully within 8 weeks with the dressing. The conclusion is that the TLC-NOSF dressing provides an effective first-line treatment alternative for chronic traumatic wounds.

1. OUR EXPERIENCE IN THE HEALING OF
TRAUMATIC WOUNDS WITH A TLC-NOSF
DRESSING*
D. PERIGNON(1) , M. MARIE(2), J. STEINBRUNN (2)
(1) Hopital Nord, Amiens, Amiens, France
(2) Laboratoires URGO, Chenôve, France
*Brand name: the TLC-NOSF dressing is UrgoStart®

2. The healing of substance losses of traumatic origin usually follows a favourable and
expected course in the absence of underlying aggravating factors (venous disease,
diabetes, immunosuppression, smoking), except in the event of secondary infection.
In addition, advanced age and the presence of ulceration over a recent, fragile scar in
the inflammatory period, are another two factors promoting poor healing.
For the latter two situations, the authors report two cases of loss of substance
treatment using TLC-NOSF dressing* following the failure of conventional dressing
treatment.
INTRODUCTION
*Brand name: the TLC-NOSF dressing is UrgoStart®

3. 76 year-old female patient with venous disease presenting stasis dermatitis and
extensive traumatic loss of skin substance, without bone exposure, on the anterior
surface of the middle third of the tibia.
After three weeks of treatment with greasy dressings, the wound remained sloughy
with peripheral necrosis.
Following mechanical desloughing, the different healing phases were obtained using
TLC-NOSF dressing* until complete wound healing was achieved.
CLINICAL CASE 1
*Brand name: the TLC-NOSF dressing is UrgoStart®

4. The wound at the
mechanical
desloughing stage
Introduction of
treatment with
TLC-NOSF dressing*
Appearance at W3
Appearance at W6 End of healing
at W9
CLINICAL CASE 1
*Brand name: the TLC-NOSF dressing is UrgoStart®

5. 23 year-old female patient, who presented necrosis subsequent to a haematoma
occurring under a total skin graft performed to cover loss of substance related to
excision of a birth mark.
The wound remained inflammatory and deep, with fragile, friable granulation tissue.
Complete healing was obtained in 2 months with TLC-NOSF dressing*, following a
first graft edge stabilisation phase and then a centripetal epithelialisation phase.
CLINICAL CASE 2
*Brand name: the TLC-NOSF dressing is UrgoStart®

6. Initial post-traumatic
appearance
Introduction of
treatment with TLC-
NOSF dressing*
Appearance at W2
Appearance at W4 W8: Complete
epithelialisation
CLINICAL CASE 2

7. These two cases illustrate our experience with TLC-NOSF dressing*,
which now constitute a first-line treatment alternative for the management of chronic
wounds of traumatic origin.
*Brand name: the TLC-NOSF dressing is UrgoStart®
CONCLUSION